|Articles|May 2, 2003
- Pharmaceutical Technology-05-02-2003
- Volume 27
- Issue 5
Drug Safety in the Limelight
Author(s)Jill Wechsler
FDA resolves the bar code labeling debate, releases its GMP requirements for dietary supplements, and proposes a comprehensive adverse-event reporting system.
Advertisement
Articles in this issue
over 22 years ago
May 2003over 22 years ago
Outsourcing Outlookover 22 years ago
The Square Root of N Plus One Sampling Ruleover 22 years ago
Particle Attrition by Particle?Surface Friction in DryersNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Drug Digest: Strategic Alliances and Technology Integration in the Evolving Biopharma Landscape
2
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
3
Excipient Innovation and the Regulatory Tug-of-War: Navigating Threats to Availability and Safety
4
US and European Pharma Manufacturing Face Diverging Paths to Resilience
5
